WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment responses of adults with HIV who are ...
Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...
Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...
At presentation, all children living with HIV younger than five years should be considered as having advanced HIV disease ...
The WHO has strongly recommended CD4 testing to identify advanced HIV disease under its 2025 guidelines. Here’s why the test ...
The World Health Organization (WHO) has strongly recommended CD4 testing as the preferred method for identifying advanced HIV ...
Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial We used data from the HIV/AIDS Cancer Match Study, a population-based HIV and cancer registry ...
CD4 tests are strongly recommended as the preferred method to identify advanced HIV disease among people living with HIV, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback